Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics
about
Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical functionAdrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate.Anesthetic drug development: Novel drugs and new approaches.Clinical and molecular pharmacology of etomidate.Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.Carboetomidate: an analog of etomidate that interacts weakly with 11β-hydroxylase.Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.The discovery of new anesthetics by targeting GABA(A) receptors.The potential of targeting CYP11B.Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016).Frequency of HNF4A-P.I463V Variant in the Tunisian North-African Population and Its Relation with Diabetes Mellitus.Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats.Sedative-hypnotic Binding to 11β-hydroxylase.[Etomidate for intravenous induction of anaesthesia].Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates.
P2860
Q33697203-08AC86A8-08DC-48E9-BCE8-3F36C15207E1Q33753539-1E0DC961-9F82-4214-9F1E-D8BC6812D634Q34710067-F981F86F-CE06-484C-9640-1AF5B54E18ABQ35024852-5CB853E4-4C52-447C-93B7-9C726F0B9A32Q35624083-AE1F77DD-C6FB-48C1-A90C-561361748D23Q37333027-75683C94-C1BD-48E9-9450-84893A8D3FD5Q37336611-D5BECB6B-9F79-4AF5-993D-3E763F2B4CA0Q38014564-78E1AF08-43EB-4C80-8924-9E276CF26210Q38725836-48BB5C9C-12A9-43C1-8847-44FBC0F266F9Q38907424-0F84A258-0833-4A80-A6C3-07E3D4F4D04EQ39769011-B58AB718-8205-44C2-A2F1-760067B751F4Q41588695-8639EF78-BA0E-4989-8FD7-2D9798C1B7C7Q42707315-3C56ACC3-617B-40A8-962E-EA83976A40C7Q49939100-1CD26ADD-537A-441E-BAD7-26CD4666F78AQ51600686-0C7F7199-8BC4-49C0-85B1-B04949D8FEDA
P2860
Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Construction of 3D models of t ...... ligand binding characteristics
@en
Construction of 3D models of t ...... ligand binding characteristics
@nl
type
label
Construction of 3D models of t ...... ligand binding characteristics
@en
Construction of 3D models of t ...... ligand binding characteristics
@nl
prefLabel
Construction of 3D models of t ...... ligand binding characteristics
@en
Construction of 3D models of t ...... ligand binding characteristics
@nl
P2093
P2860
P1476
Construction of 3D models of t ...... ligand binding characteristics
@en
P2093
Dirk Leysen
Erica Custers
Harry C J Ottenheijm
Ilona Beugels
J J R Hermans
Jos F M Smits
Judith Emmen
Koen Pieterse
Luc Roumen
Marcel de Gooyer
P2860
P2888
P304
P356
10.1007/S10822-007-9128-9
P577
2007-07-24T00:00:00Z
P5875
P6179
1004757034